Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription Articles published in Biochem Biophys Res Commun Retrieve available abstracts of 122 articles: HTML format

Single Articles

May 2024
1. KALASHNYK O, Lykhmus O, Sullivan R, Komisarenko S, et al
   Agonists or positive allosteric modulators of alpha7 nicotinic acetylcholine receptor prevent interaction of SARS-Cov-2 receptor-binding domain with astrocytoma cells.
   Biochem Biophys Res Commun. 2024;709:149825.
   PubMed     Abstract available
   
   
   
2. SU L, Lou Y, Li J, Mao H, et al
   Influence of storage solution, temperature, assay time and concentration on RT-qPCR nucleic acid detection for SARS-CoV-2 detection of SARS-CoV-2 by the RT-qPCR.
   Biochem Biophys Res Commun. 2024;707:149726.
   PubMed     Abstract available
   
   
   March 2024
3. HE K, Ye Y, Liu S, Yuan P, et al
   Polylevodopa nanoplatform for lateral flow immunochromatography assay of SARS-CoV-2 and influenza A virus.
   Biochem Biophys Res Commun. 2024;709:149821.
   PubMed     Abstract available
   
   
   
4. KIM HJ, Han CW, Jeong MS, Jang SB, et al
   Cryo-EM structure of Influenza A virus NS1 and antiviral protein kinase PKR complex.
   Biochem Biophys Res Commun. 2024;706:149728.
   PubMed     Abstract available
   
   
   January 2024
5. SAITO T, Couzinet A, Murakami T, Shimomura M, et al
   Rapid and high throughput assessment of cellular immunity against SARS-CoV-2 based on the ex vivo activation of genes in leukocyte assay with whole blood.
   Biochem Biophys Res Commun. 2024;694:149398.
   PubMed     Abstract available
   
   
   
6. NASSAR K, El-Mekawey D, Elmasry AE, Refaey MS, et al
   The significance of caloric restriction mimetics as anti-aging drugs.
   Biochem Biophys Res Commun. 2024;692:149354.
   PubMed     Abstract available
   
   
   
7. JIANG H, Zou X, Zhou X, Zhang J, et al
   Crystal structure of SARS-CoV-2 main protease (M(pro)) mutants in complex with the non-covalent inhibitor CCF0058981.
   Biochem Biophys Res Commun. 2024;692:149352.
   PubMed     Abstract available
   
   
   December 2023
8. KAWAHARA E, Yamamoto S, Shibata T, Hirai T, et al
   CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial virus infection in the upper respiratory tract via CD4(+) T cells.
   Biochem Biophys Res Commun. 2023;686:149143.
   PubMed     Abstract available
   
   
   
9. ZHANG L, Zhang X, Deng X, Wang P, et al
   Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis.
   Biochem Biophys Res Commun. 2023;686:149118.
   PubMed     Abstract available
   
   
   November 2023
10. CARONIA L, Xi R, Margolskee RF, Jiang P, et al
    Paxlovid mouth likely is mediated by activation of the TAS2R1 bitter receptor by nirmatrelvir.
    Biochem Biophys Res Commun. 2023;682:138-140.
    PubMed     Abstract available
    
    
    October 2023
11. JIANG S, Yang H, Sun Z, Zhang Y, et al
    The basis of complications in the context of SARS-CoV-2 infection: Pathological activation of ADAM17.
    Biochem Biophys Res Commun. 2023;679:37-46.
    PubMed     Abstract available
    
    
    
12. FRASER-PITT D, Mercer DK, Francis ML, Toledo-Aparicio D, et al
    Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection.
    Biochem Biophys Res Commun. 2023;677:168-181.
    PubMed     Abstract available
    
    
    
13. YAO Y, Zhang Y, Li Z, Chen Z, et al
    A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
    Biochem Biophys Res Commun. 2023;675:113-121.
    PubMed     Abstract available
    
    
    September 2023
14. FUJISAWA M, Adachi Y, Onodera T, Shiwa-Sudo N, et al
    High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection.
    Biochem Biophys Res Commun. 2023;673:114-120.
    PubMed     Abstract available
    
    
    August 2023
15. SUN W, Zhang Z, Chen M, Liu X, et al
    Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase.
    Biochem Biophys Res Commun. 2023;678:97-101.
    PubMed     Abstract available
    
    
    
16. YU J, Im H, Lee G
    Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca(2+), elucidated by biochemical and single-molecular studies.
    Biochem Biophys Res Commun. 2023;668:35-41.
    PubMed     Abstract available
    
    
    July 2023
17. BEAUDOIN CA, Petsolari E, Hamaia SW, Hala S, et al
    SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
    Biochem Biophys Res Commun. 2023;666:61-67.
    PubMed     Abstract available
    
    
    June 2023
18. ISHII H, Jounai K, Tsuji R, Ohshio K, et al
    Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication.
    Biochem Biophys Res Commun. 2023;662:26-30.
    PubMed     Abstract available
    
    
    
19. CHU X, Ding X, Yang Y, Lu Y, et al
    Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2.
    Biochem Biophys Res Commun. 2023;660:43-49.
    PubMed     Abstract available
    
    
    May 2023
20. ITO K, Goto K, Shirakawa R, Horiuchi H, et al
    Platelet alphaIIbbeta3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains.
    Biochem Biophys Res Commun. 2023;657:80-85.
    PubMed     Abstract available
    
    
    
21. ZHOU Y, Wang W, Zeng P, Feng J, et al
    Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332.
    Biochem Biophys Res Commun. 2023;657:16-23.
    PubMed     Abstract available
    
    
    February 2023
22. AHN MJ, Kang JA, Hong SM, Lee KS, et al
    Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera.
    Biochem Biophys Res Commun. 2023;646:8-18.
    PubMed     Abstract available
    
    
    
23. KAWASHIMA S, Matsui Y, Adachi T, Morikawa Y, et al
    Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally.
    Biochem Biophys Res Commun. 2023;645:132-136.
    PubMed     Abstract available
    
    
    
24. HOSSAIN MI, Myers M, Herath D, Aldhumani AH, et al
    4-Aminoquinolines modulate RNA structure and function: Pharmacophore implications of a conformationally restricted polyamine.
    Biochem Biophys Res Commun. 2023;644:55-61.
    PubMed     Abstract available
    
    
    January 2023
25. CHARLES J, McCann N, Ploplis VA, Castellino FJ, et al
    Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein.
    Biochem Biophys Res Commun. 2023;641:61-66.
    PubMed     Abstract available
    
    
    November 2022
26. MUHAMMAD JS, ElGhazali G, Shafarin J, Mohammad MG, et al
    SARS-CoV-2-induced hypomethylation of the ferritin heavy chain (FTH1) gene underlies serum hyperferritinemia in severe COVID-19 patients.
    Biochem Biophys Res Commun. 2022;631:138-145.
    PubMed     Abstract available
    
    
    
27. PADHI AK, Tripathi T
    Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes.
    Biochem Biophys Res Commun. 2022;629:54-60.
    PubMed     Abstract available
    
    
    October 2022
28. CHAKRABORTY S, Saha A, Saha C, Ghosh S, et al
    Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants.
    Biochem Biophys Res Commun. 2022;627:168-175.
    PubMed     Abstract available
    
    
    
29. ZHAO H, Liu J, He L, Zhang L, et al
    Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10.
    Biochem Biophys Res Commun. 2022;626:114-120.
    PubMed     Abstract available
    
    
    
30. CHOI JY, Park JH, Jo C, Kim KC, et al
    SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells.
    Biochem Biophys Res Commun. 2022;626:66-71.
    PubMed     Abstract available
    
    
    
31. OKI N, Yamada S, Tanaka T, Fukui H, et al
    Curcumin partly prevents ISG15 activation via ubiquitin-activating enzyme E1-like protein and decreases ISGylation.
    Biochem Biophys Res Commun. 2022;625:94-101.
    PubMed     Abstract available
    
    
    
32. POURFARJAM Y, Ma Z, Kim IK
    ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase.
    Biochem Biophys Res Commun. 2022;625:53-59.
    PubMed     Abstract available
    
    
    September 2022
33. LYKHMUS O, Kalashnyk O, Koval L, Krynina O, et al
    Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice.
    Biochem Biophys Res Commun. 2022;622:57-63.
    PubMed     Abstract available
    
    
    
34. MISHRA PM, Anjum F, Uversky VN, Nandi CK, et al
    SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors.
    Biochem Biophys Res Commun. 2022;620:8-14.
    PubMed     Abstract available
    
    
    August 2022
35. LI H, Ren H, Cao L, Guo J, et al
    Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice.
    Biochem Biophys Res Commun. 2022;618:54-60.
    PubMed     Abstract available
    
    
    
36. WEI W, Kong N, Liu MZ, Han T, et al
    Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease.
    Biochem Biophys Res Commun. 2022;616:8-13.
    PubMed     Abstract available
    
    
    
37. ZHANG B, Li Y, Feng Q, Song L, et al
    Structural insights into ORF10 recognition by ZYG11B.
    Biochem Biophys Res Commun. 2022;616:14-18.
    PubMed     Abstract available
    
    
    July 2022
38. SUGAMOTO K, Tanaka YL, Saito A, Goto Y, et al
    Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes.
    Biochem Biophys Res Commun. 2022;615:56-62.
    PubMed     Abstract available
    
    
    
39. MINAGAWA H, Sawa H, Fujita T, Kato S, et al
    A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant).
    Biochem Biophys Res Commun. 2022;614:207-212.
    PubMed     Abstract available
    
    
    
40. DUAN L, Yin H, Liu J, Wang W, et al
    Fetal neurodevelopmental spatio-temporal dynamic transcriptional landscape of maternal insult-induce autism spectrum disorder risk.
    Biochem Biophys Res Commun. 2022;614:183-190.
    PubMed     Abstract available
    
    
    June 2022
41. BEHERA J, Ison J, Voor MJ, Tyagi SC, et al
    Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss.
    Biochem Biophys Res Commun. 2022;620:180-187.
    PubMed     Abstract available
    
    
    May 2022
42. MIYOSHI H, Ichinohe R, Koshikawa T
    High-resolution melting analysis after nested PCR for the detection of SARS-CoV-2 spike protein G339D and D796Y variations.
    Biochem Biophys Res Commun. 2022;606:128-134.
    PubMed     Abstract available
    
    
    
43. WANG L, Zhao L, Li Y, Ma P, et al
    Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through a novel baculovirus surface display system.
    Biochem Biophys Res Commun. 2022;606:23-28.
    PubMed     Abstract available
    
    
    
44. LIU P, Zhang Y, Li Z, Huang J, et al
    Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2.
    Biochem Biophys Res Commun. 2022;606:17-22.
    PubMed     Abstract available
    
    
    
45. GHAZANFARI D, Courreges MC, Belinski L, Bergmeier SC, et al
    Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19.
    Biochem Biophys Res Commun. 2022;605:171-176.
    PubMed     Abstract available
    
    
    
46. WU Q, Yan S, Wang Y, Li M, et al
    Discovery of 4'-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor.
    Biochem Biophys Res Commun. 2022;604:76-82.
    PubMed     Abstract available
    
    
    April 2022
47. YUE K, Yao B, Shi Y, Yang Y, et al
    The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
    Biochem Biophys Res Commun. 2022;601:129-136.
    PubMed     Abstract available
    
    
    February 2022
48. HEALY EF
    How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17.
    Biochem Biophys Res Commun. 2022;593:52-56.
    PubMed     Abstract available
    
    
    
49. KOLEY T, Kumar M, Goswami A, Ethayathulla AS, et al
    Structural modeling of Omicron spike protein and its complex with human ACE-2 receptor: Molecular basis for high transmissibility of the virus.
    Biochem Biophys Res Commun. 2022;592:51-53.
    PubMed     Abstract available
    
    
    
50. RATH SL, Padhi AK, Mandal N
    Scanning the RBD-ACE2 molecular interactions in Omicron variant.
    Biochem Biophys Res Commun. 2022;592:18-23.
    PubMed     Abstract available
    
    
    
51. LEE JW, Kim MN, Kim EG, Leem JS, et al
    Chitinase 3-like 1 is involved in the induction of IL-8 expression by double-stranded RNA in airway epithelial cells.
    Biochem Biophys Res Commun. 2022;592:106-112.
    PubMed     Abstract available
    
    
    
52. CHEN J, Zhang Y, Zeng D, Zhang B, et al
    Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2.
    Biochem Biophys Res Commun. 2022;591:118-123.
    PubMed     Abstract available
    
    
    
53. MAO XD, Li T, Xu Z, Liu K, et al
    Pathogenesis of COVID-19 and the quality control of nucleic acid detection.
    Biochem Biophys Res Commun. 2022;591:137-142.
    PubMed     Abstract available
    
    
    
54. CHIOU WC, Chen JC, Chen YT, Yang JM, et al
    The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease.
    Biochem Biophys Res Commun. 2022;591:130-136.
    PubMed     Abstract available
    
    
    January 2022
55. LUPALA CS, Ye Y, Chen H, Su XD, et al
    Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
    Biochem Biophys Res Commun. 2022;590:34-41.
    PubMed     Abstract available
    
    
    
56. HOSHINO F, Sakane F
    Docosahexaenoic acid-containing phosphatidic acid interacts with clathrin coat assembly protein AP180 and regulates its interaction with clathrin.
    Biochem Biophys Res Commun. 2022;587:69-77.
    PubMed     Abstract available
    
    
    
57. MAKIYAMA K, Hazawa M, Kobayashi A, Lim K, et al
    NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells.
    Biochem Biophys Res Commun. 2022;586:137-142.
    PubMed     Abstract available
    
    
    
58. OSTROV DA, Knox GW
    Emerging mutation patterns in SARS-CoV-2 variants.
    Biochem Biophys Res Commun. 2022;586:87-92.
    PubMed     Abstract available
    
    
    November 2021
59. VICTOR J, Deutsch J, Whitaker A, Lamkin EN, et al
    SARS-CoV-2 triggers DNA damage response in Vero E6 cells.
    Biochem Biophys Res Commun. 2021;579:141-145.
    PubMed     Abstract available
    
    
    
60. ZHENG L, Ma Y, Chen M, Wu G, et al
    SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells.
    Biochem Biophys Res Commun. 2021;579:69-75.
    PubMed     Abstract available
    
    
    
61. RYU DK, Kang B, Noh H, Woo SJ, et al
    The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;578:91-96.
    PubMed     Abstract available
    
    
    
62. SASAKI M, Kishimoto M, Itakura Y, Tabata K, et al
    Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells.
    Biochem Biophys Res Commun. 2021;577:146-151.
    PubMed     Abstract available
    
    
    October 2021
63. BARAL P, Bhattarai N, Hossen ML, Stebliankin V, et al
    Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.
    Biochem Biophys Res Commun. 2021;574:14-19.
    PubMed     Abstract available
    
    
    September 2021
64. LONG Y, Song S, Luo F, Han X, et al
    A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding.
    Biochem Biophys Res Commun. 2021;571:152-158.
    PubMed     Abstract available
    
    
    
65. BEGUM F, Srivastava AK, Ray U
    Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
    Biochem Biophys Res Commun. 2021;571:26-31.
    PubMed     Abstract available
    
    
    
66. OBA M, Rongduo W, Saito A, Okabayashi T, et al
    Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro.
    Biochem Biophys Res Commun. 2021;570:21-25.
    PubMed     Abstract available
    
    
    August 2021
67. RYU DK, Song R, Kim M, Kim YI, et al
    Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
    Biochem Biophys Res Commun. 2021;566:135-140.
    PubMed     Abstract available
    
    
    
68. JIN D, Wei J, Sun J
    Analysis of the molecular mechanism of SARS-CoV-2 antibodies.
    Biochem Biophys Res Commun. 2021;566:45-52.
    PubMed     Abstract available
    
    
    
69. HUANG RY, Herr DR
    Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein.
    Biochem Biophys Res Commun. 2021;565:8-13.
    PubMed     Abstract available
    
    
    July 2021
70. OHKI S, Imamura T, Higashimura Y, Matsumoto K, et al
    Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant.
    Biochem Biophys Res Commun. 2021;563:92-97.
    PubMed     Abstract available
    
    
    June 2021
71. HATAKEYAMA D, Masuda T, Miki R, Ohtsuki S, et al
    In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
    Biochem Biophys Res Commun. 2021;557:273-279.
    PubMed     Abstract available
    
    
    
72. ZHAO L, Hao Y, Song Z, Fan Y, et al
    TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
    Biochem Biophys Res Commun. 2021;556:87-92.
    PubMed     Abstract available
    
    
    May 2021
73. PADHI AK, Tripathi T
    Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation.
    Biochem Biophys Res Commun. 2021;555:147-153.
    PubMed     Abstract available
    
    
    
74. VANDYCK K, Abdelnabi R, Gupta K, Jochmans D, et al
    ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model.
    Biochem Biophys Res Commun. 2021;555:134-139.
    PubMed     Abstract available
    
    
    
75. CAO B, Kang T
    Nonlinear adaptive control of COVID-19 with media campaigns and treatment.
    Biochem Biophys Res Commun. 2021;555:202-209.
    PubMed     Abstract available
    
    
    
76. IDREES D, Kumar V
    SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration.
    Biochem Biophys Res Commun. 2021;554:94-98.
    PubMed     Abstract available
    
    
    
77. KRUSE RL, Huang Y, Smetana H, Gehrie EA, et al
    A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.
    Biochem Biophys Res Commun. 2021;553:165-171.
    PubMed     Abstract available
    
    
    
78. ZHANG Y, Niu G, Flisikowska T, Schnieke A, et al
    A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs.
    Biochem Biophys Res Commun. 2021;553:25-29.
    PubMed     Abstract available
    
    
    April 2021
79. PEREIRA F
    SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
    Biochem Biophys Res Commun. 2021;550:8-14.
    PubMed     Abstract available
    
    
    March 2021
80. SHIBUYA M, Tamiya S, Kawai A, Yoshioka Y, et al
    Nasal-subcutaneous prime-boost regimen for inactivated whole-virus influenza vaccine efficiently protects mice against both upper and lower respiratory tract infections.
    Biochem Biophys Res Commun. 2021;554:166-172.
    PubMed     Abstract available
    
    
    
81. SAKURAI Y, Ngwe Tun MM, Kurosaki Y, Sakura T, et al
    5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro.
    Biochem Biophys Res Commun. 2021;545:203-207.
    PubMed     Abstract available
    
    
    
82. ADAMI EA, Chavez Rico SL, Akamatsu MA, Miyaki C, et al
    H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.
    Biochem Biophys Res Commun. 2021;545:145-149.
    PubMed     Abstract available
    
    
    
83. SMITS VAJ, Hernandez-Carralero E, Paz-Cabrera MC, Cabrera E, et al
    The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
    Biochem Biophys Res Commun. 2021;543:45-49.
    PubMed     Abstract available
    
    
    January 2021
84. INTAWONG K, Olson D, Chariyalertsak S
    Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
    Biochem Biophys Res Commun. 2021;538:231-237.
    PubMed     Abstract available
    
    
    
85. SANTORO MG, Carafoli E
    Remdesivir: From Ebola to COVID-19.
    Biochem Biophys Res Commun. 2021;538:145-150.
    PubMed     Abstract available
    
    
    
86. MOORE KM, Suthar MS
    Comprehensive analysis of COVID-19 during pregnancy.
    Biochem Biophys Res Commun. 2021;538:180-186.
    PubMed     Abstract available
    
    
    
87. VIANELLO C, Strozzi F, Mocellin P, Cimetta E, et al
    A perspective on early detection systems models for COVID-19 spreading.
    Biochem Biophys Res Commun. 2021;538:244-252.
    PubMed     Abstract available
    
    
    
88. PASETTO D, Lemaitre JC, Bertuzzo E, Gatto M, et al
    Range of reproduction number estimates for COVID-19 spread.
    Biochem Biophys Res Commun. 2021;538:253-258.
    PubMed     Abstract available
    
    
    
89. JANS DA, Wagstaff KM
    The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
    Biochem Biophys Res Commun. 2021;538:163-172.
    PubMed     Abstract available
    
    
    
90. REZNIKOV LR, Norris MH, Vashisht R, Bluhm AP, et al
    Identification of antiviral antihistamines for COVID-19 repurposing.
    Biochem Biophys Res Commun. 2021;538:173-179.
    PubMed     Abstract available
    
    
    
91. SANTOPOLO S, Riccio A, Santoro MG
    The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy.
    Biochem Biophys Res Commun. 2021;538:80-87.
    PubMed     Abstract available
    
    
    
92. BACCA E, Digaetano M, Meschiari M, Franceschini E, et al
    Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature.
    Biochem Biophys Res Commun. 2021;538:151-155.
    PubMed     Abstract available
    
    
    
93. WATASHI K
    Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
    Biochem Biophys Res Commun. 2021;538:137-144.
    PubMed     Abstract available
    
    
    
94. WALSH MA, Grimes JM, Stuart DI
    Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics.
    Biochem Biophys Res Commun. 2021;538:40-46.
    PubMed     Abstract available
    
    
    
95. MOURIER T, Sadykov M, Carr MJ, Gonzalez G, et al
    Host-directed editing of the SARS-CoV-2 genome.
    Biochem Biophys Res Commun. 2021;538:35-39.
    PubMed     Abstract available
    
    
    
96. CHENG HY, Huang AS
    Proactive and blended approach for COVID-19 control in Taiwan.
    Biochem Biophys Res Commun. 2021;538:238-243.
    PubMed     Abstract available
    
    
    
97. KALFAOGLU B, Almeida-Santos J, Tye CA, Satou Y, et al
    T-cell dysregulation in COVID-19.
    Biochem Biophys Res Commun. 2021;538:204-210.
    PubMed     Abstract available
    
    
    
98. JACKSON CB, Zhang L, Farzan M, Choe H, et al
    Functional importance of the D614G mutation in the SARS-CoV-2 spike protein.
    Biochem Biophys Res Commun. 2021;538:108-115.
    PubMed     Abstract available
    
    
    
99. KENNY G, Mallon PW
    COVID19- clinical presentation and therapeutic considerations.
    Biochem Biophys Res Commun. 2021;538:125-131.
    PubMed     Abstract available
    
    
    
100. SCHENKELBERG T
     Vaccine-induced protection in aging adults and pandemic response.
     Biochem Biophys Res Commun. 2021;538:218-220.
     PubMed    
     
     
     
101. PLATTO S, Wang Y, Zhou J, Carafoli E, et al
     History of the COVID-19 pandemic: Origin, explosion, worldwide spreading.
     Biochem Biophys Res Commun. 2021;538:14-23.
     PubMed     Abstract available
     
     
     
102. GROVES DC, Rowland-Jones SL, Angyal A
     The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
     Biochem Biophys Res Commun. 2021;538:104-107.
     PubMed     Abstract available
     
     
     
103. GIOVANETTI M, Benedetti F, Campisi G, Ciccozzi A, et al
     Evolution patterns of SARS-CoV-2: Snapshot on its genome variants.
     Biochem Biophys Res Commun. 2021;538:88-91.
     PubMed     Abstract available
     
     
     
104. DIPIAZZA AT, Graham BS, Ruckwardt TJ
     T cell immunity to SARS-CoV-2 following natural infection and vaccination.
     Biochem Biophys Res Commun. 2021;538:211-217.
     PubMed     Abstract available
     
     
     
105. CARRILLO J, Izquierdo-Useros N, Avila-Nieto C, Pradenas E, et al
     Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity.
     Biochem Biophys Res Commun. 2021;538:187-191.
     PubMed     Abstract available
     
     
     
106. SARVER DC, Wong GW
     Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19.
     Biochem Biophys Res Commun. 2021;538:92-96.
     PubMed     Abstract available
     
     
     
107. BAXTER C, Abdool Karim Q, Abdool Karim SS
     Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives.
     Biochem Biophys Res Commun. 2021;538:221-225.
     PubMed    
     
     
     
108. LAI CKC, Lam W
     Laboratory testing for the diagnosis of COVID-19.
     Biochem Biophys Res Commun. 2021;538:226-230.
     PubMed     Abstract available
     
     
     
109. FANTINI J, Chahinian H, Yahi N
     Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
     Biochem Biophys Res Commun. 2021;538:132-136.
     PubMed     Abstract available
     
     
     
110. PLATTO S, Zhou J, Wang Y, Wang H, et al
     Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease.
     Biochem Biophys Res Commun. 2021;538:2-13.
     PubMed     Abstract available
     
     
     
111. ZINZULA L, Basquin J, Bohn S, Beck F, et al
     High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
     Biochem Biophys Res Commun. 2021;538:54-62.
     PubMed     Abstract available
     
     
     
112. CARAFOLI E
     Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection.
     Biochem Biophys Res Commun. 2021;538:156-162.
     PubMed     Abstract available
     
     
     
113. JIANG Y, Yin W, Xu HE
     RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.
     Biochem Biophys Res Commun. 2021;538:47-53.
     PubMed     Abstract available
     
     
     
114. 
     Editorial.
     Biochem Biophys Res Commun. 2021;538:1.
     PubMed    
     
     
     
115. CHAKRABORTY S
     Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
     Biochem Biophys Res Commun. 2021;538:97-103.
     PubMed     Abstract available
     
     
     
116. GU L, Zhou Y, Wang G, Deng H, et al
     Spatial learning and memory impaired after infection of non-neurotropic influenza virus in BALB/c male mice.
     Biochem Biophys Res Commun. 2021;540:29-36.
     PubMed     Abstract available
     
     
     
117. SHARMA A, Preece B, Swann H, Fan X, et al
     Structural stability of SARS-CoV-2 virus like particles degrades with temperature.
     Biochem Biophys Res Commun. 2021;534:343-346.
     PubMed     Abstract available
     
     
     
118. INTAWONG K, Olson D, Chariyalertsak S
     Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand.
     Biochem Biophys Res Commun. 2021;534:830-836.
     PubMed     Abstract available
     
     
     
119. LIMA MA, Skidmore M, Khanim F, Richardson A, et al
     Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2.
     Biochem Biophys Res Commun. 2021;534:485-490.
     PubMed     Abstract available
     
     
     
120. CHAKRABORTY S
     Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
     Biochem Biophys Res Commun. 2021;534:374-380.
     PubMed     Abstract available
     
     
     November 2020
121. JEREMIAH SS, Miyakawa K, Morita T, Yamaoka Y, et al
     Potent antiviral effect of silver nanoparticles on SARS-CoV-2.
     Biochem Biophys Res Commun. 2020;533:195-200.
     PubMed     Abstract available
     
     
     October 2020
122. TUNG HYL, Limtung P
     Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3.
     Biochem Biophys Res Commun. 2020;532:134-138.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.